IRIS

Sfoglia per Titolo

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 16.010 a 16.029 di 29.890
Titolo Data di pubblicazione Autore(i) File
Lupus eritematoso sistemico 1-gen-2011 Gremese, E; Ferraccioli, G
LUPUS ERITEMATOSO SISTEMICO AD ESORDIO TARDIVO: CARATTERISTICHE CLINICHE ED IMMUNOLOGICHE 1-gen-2009 Cartella, Stefania; Inverardi, F; Ceribelli, Angela; Cavazzana, Ilaria; Tincani, Angela; Cattaneo, Roberto; Franceschini, F.
Lupus Membranous Nephropathy 1-gen-2021 Ponticelli, Claudio; Moroni, Gabriella; Fornoni, Alessia
Lupus membranous nephropathy: long-term outcome 1-gen-1993 Pasquali, S; Banfi, G; Zucchelli, A; Moroni, G; Ponticelli, C; Zucchelli, P
Lupus nephritis 1-gen-2000 Ponticelli, C; Moroni, G; Gusmano, R; Barbano, G; Zucchelli, P; Vendemia, F; Bertani, T; Sinico, Ra; Di Belgiojoso, Gb; Bazzi, C
Lupus nephritis: clinical presentations and outcomes in the 21st century 1-gen-2020 Gasparotto, Michela; Gatto, Mariele; Binda, Valentina; Doria, Andrea; Moroni, Gabriella
Lupus nephritis: low urinary DNase I levels reflect loss of renal DNase I and may be utilized as a biomarker of disease progression 1-gen-2018 Pedersen, Hl; Horvei, Kd; Thiyagarajan, D; Norby, Ge; Seredkina, N; Moroni, G; Eilertsen, Gø; Holdaas, H; Strøm, Eh; Bakland, G; Meroni, Pl; Rekvig, Op
Lupus nephritis: When and how often to biopsy and what does it mean? 1-gen-2016 Moroni, G; Depetri, F; Ponticelli, C
Lupus T cells switched on by DNA hypomethylation via microRNA? 1-gen-2011 Ceribelli, Angela; Yao, Bing; Dominguez-Gutierrez, Paul R; Chan, Edward K L
Lurbinectedin (PM01183): Antineoplastic Activity in Murine and Human Experimental Models 1-gen-2012 Fraoolli, R; Bello, E; Zangarini, M; Zucchetti, P; Aviles, P; D'Incalci, M
Lurbinectedin as a second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial 1-gen-2020 Trigo, J; Subbiah, V; Besse, B; Moreno, V; Lopez, R; Sala, M A; Peters, S; Ponce, S; Fernandez, C; Alfaro, V; Gomez, J; Kahatt, C; Zeaiter, A; Zaman, K; Boni, V; Arrondeau, J; Martinez, M; Delord, J P; Awada, A; Kristeleit, R; Olmedo, M E; Wannesson, L; Valdivia, J; Rubio, M J; Anton, A; Sarantopoulos, J; Chawla, S P; Mosuqera-Martinez, J; D’Arcangelo, M; Santoro, A; Villalobos, V M; Sands, J; Paz-Ares, L
Lurbinectedin as second- or third-line palliative therapy in malignant pleural mesothelioma: an international, multi-centre, single-arm, phase II trial (SAKK 17/16) 1-gen-2020 Metaxas, Y; Früh, M; Eboulet, E I; Grosso, F; Pless, M; Zucali, P A; Ceresoli, G L; Mark, M; Schneider, M; Maconi, A; Perrino, M; Biaggi-Rudolf, C; Froesch, P; Schmid, S; Waibel, C; Appenzeller, C; Rauch, D; von Moos, R
Lurbinectedin Inactivates the Ewing Sarcoma Oncoprotein EWS-FLI1 by Redistributing It within the Nucleus 1-gen-2016 Harlow, Ml; Maloney, N; Roland, J; Navarro, Mjg; Easton, M; Kitchen-Goosen, Sm; Boguslawski, Ea; Madaj, Zb; Johnson, Bk; Bowman, Mj; D'Incalci, M; Winn, Me; Turner, L; Hostetter, G; Galmarini, Cm; Aviles, Pm; Grohar, Pj
Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models 1-gen-2017 Belgiovine, C; Bello, E; Liguori, M; Craparotta, I; Mannarino, L; Paracchini, L; Beltrame, L; Marchini, S; Galmarini, Cm; Mantovani, A; Frapolli, R; Allavena, P; D'Incalci, M
Lurbinectedin versus pegylated liposomal doxorubicin or topotecan in patients with platinum-resistant ovarian cancer: A multicenter, randomized, controlled, open-label phase 3 study (CORAIL) 1-gen-2021 Gaillard, S; Oaknin, A; Ray-Coquard, I; Vergote, I; Scambia, G; Colombo, N; Fernandez, C; Alfaro, V; Kahatt, C; Nieto, A; Zeaiter, A; Aracil, M; Vidal, L; Pardo-Burdalo, B; Papai, Z; Kristeleit, R; O'Malley, Dm; Benjamin, I; Pautier, P; Lorusso, D
The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu]Lu-DOTATATE 1-gen-2024 Maccauro, Marco; Cuomo, Mariarosaria; Bauckneht, Matteo; Bagnalasta, Matteo; Mazzaglia, Stefania; Scalorbi, Federica; Argiroffi, Giovanni; Kirienko, Margarita; Lorenzoni, Alice; Aliberti, Gianluca; Pusceddu, Sara; Giuseppina, Calareso; Matteo, Garanzini Enrico; Seregni, Ettore; Chiesa, Carlo
Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE 1-gen-2023 Urso, Luca; Nieri, Alberto; Uccelli, Licia; Castello, Angelo; Artioli, Paolo; Cittanti, Corrado; Marzola, Maria Cristina; Florimonte, Luigia; Castellani, Massimo; Bissoli, Sergio; Porto, Francesca; Boschi, Alessandra; Evangelista, Laura; Bartolomei, Mirco
Lutein in chromovitrectomy: biocompatibility and efficacy 1-gen-2015 Romano, Mario R.
Luteinizing hormone supplementation in women with hypogonadotropic hypogonadism seeking fertility care: Insights from a narrative review 1-gen-2022 Di Segni, Noemi; Busnelli, Andrea; Secchi, Matteo; Cirillo, Federico; Levi-Setti, Paolo Emanuele
Lutetium-177-G250 radioimmunotherapy in an intraperitoneal clear cell renal cell carcinoma xenograft model 1-gen-2013 Muselaers, Chj; Bos, Dl; Mulders, Pfa; Oosterwijk, E; Oyen, W; Boerman, Oc
Mostrati risultati da 16.010 a 16.029 di 29.890
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile